Here are relevant reports on : molecular-diagnostics-market
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market, valued at US$0.2 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The growth of this market is primarily driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Waterborne Epoxy Resin Market by Type (High Molecular Weight, Low Molecular Weight), Application (Coatings, Adhesives, and Composites), End-use Industry (Construction, Automotive, Textile, Packaging, and Furniture), and Region - Global Forecasts to 2022
The waterborne epoxy resin market is estimated to be USD 2.79 Billion in 2017 and projected to grow at a CAGR of 9.1% during the forecast period between 2017 and 2021. The market is segmented on the basis of type, application, end-use industry, and region. Hexion Inc. (US), Allnex GmbH (Germany), Huntsman Corporation (US), Evonik Industries AG (Germany), Olin Corporation (US), Kukdo Chemical Co., Ltd. (South Korea), Aditya Birla Chemicals (Thailand) Ltd. (Thailand), Reichhold LLC (U.S.), Nan Ya Plastics Corporation (Taiwan), ADEKA Corporation (Japan), DIC Corporation (Japan), Spolchemie A.S. (Czech Republic), Resoltech (France), LEUNA-Harze GmbH (Germany), Helios Resins (Slovenia), and Kumho P&B Chemicals Inc. (South Korea) are the players operating in the waterborne epoxy resin market.
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
The global molecular diagnostics market, valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of US$30.74 billion by the end of the period. The Asia Pacific market is projected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and rapid expansion of medical infrastructure in Asia Pacific countries.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Point-of-Care Molecular Diagnostics Market by Product & Service (Assays, Instruments, Software), Technology (RT-PCR, INAAT), Sample Type (Blood, Urine), Application (STD, HAI, Hepatitis, Cancer), and End User (Hospitals, Clinics) - Global Forecast to 2030
The global point-of-care molecular diagnostics market, valued at US$4.01 billion in 2024, stood at US$4.30 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of US$7.09 billion by the end of the period. The market is experiencing strong growth due to increasing demand for timely and accessible testing solutions. A major factor is the rising prevalence of infectious diseases and cancer, which has created a growing need for fast and reliable diagnostics.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Companion Animal Health Market by Animal Type (Dogs, Cats), Product (Vaccines, Pharmaceuticals, Diagnostics), End User (Veterinary Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2027
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
